BETA

IPO registrations (S-1, F-1) · Registrants

DYNAVAX TECHNOLOGIES CORP

SEC CIK
1029142 · filings on EDGAR ↗
Registration
Form S-1, first filed 2000-12-05, last 2004-02-11; 2 initial registrations, 5 amendments
Outcome
Final prospectus filed 2004-02-20; withdrawal requested 2001-04-24
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
2100 POWELL STREET, SUITE 720, Emeryville, CA 94608
EIN
33-0728374
EDGAR entity type
operating
Insiders and CEO pay
DYNAVAX TECHNOLOGIES CORP on the corporate pages

Offering terms

Proposed price range
$12.00–$14.00 per share (S-1/A filed 2004-02-05)
Final price
$7.50 per share, below the range (424B4 filed 2004-02-20, an initial public offering)
Shares sold
6,000,000
Gross proceeds
$45,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol DVAX
Lead underwriters
Bear Stearns; Deutsche Bank (2,400,000 shares); Piper Sandler (1,200,000 shares)
Syndicate
below. Bear, Stearns & Co. Inc (2,400,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 9

FiledFormWhat it isName as filedEDGAR
2000-12-05S-1S-1 (registration)DYNAVAX TECHNOLOGIES CORP0000912057-00-052288 ↗
2001-04-24RWRW (withdrawal request)DYNAVAX TECHNOLOGIES CORP0000912057-01-510017 ↗
2003-10-24S-1S-1 (registration)DYNAVAX TECHNOLOGIES CORP0000950149-03-002410 ↗
2003-12-01S-1/AS-1/A (amendment)DYNAVAX TECHNOLOGIES CORP0000950149-03-002829 ↗
2003-12-05S-1/AS-1/A (amendment)DYNAVAX TECHNOLOGIES CORP0000950149-03-002856 ↗
2004-01-16S-1/AS-1/A (amendment)DYNAVAX TECHNOLOGIES CORP0000950149-04-000149 ↗
2004-02-05S-1/AS-1/A (amendment)DYNAVAX TECHNOLOGIES CORP0000950149-04-000279 ↗
2004-02-11S-1/AS-1/A (amendment)DYNAVAX TECHNOLOGIES CORP0000950149-04-000353 ↗
2004-02-20424B4424B4 (final prospectus)DYNAVAX TECHNOLOGIES CORP0000950149-04-000438 ↗

Prospectus pages read 3

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2004-02-05S-1/Aregistration statement$12.00–$14.006,000,000-Nasdaq DVAX6primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, underwriting table 3document ↗
2004-02-11S-1/Aregistration statement--0primary document; no terms founddocument ↗
2004-02-20424B4final prospectus$7.506,000,000$45,000,000Nasdaq DVAX4primary document; price sentence, shares headline, proceeds table, underwriting table 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Flynn James ETenPercentOwner202006–2008person page Fuzzy
COFFMAN ROBERTOfficerChief Science Officer and VP; Chief Scientific Officer & SVP; Chief Scientific Officer & VP; Senior Vice President352006–2019
HENN TIMOTHY GOfficerVice President; VP, Finance & Administration22006–2007
LEVITT DANIEL JOfficerVice President12006
SMELTZER DEBORAH AOfficerVice President and CFO; VP Operations and CFO; VP, Operations & CFO52006–2009
TUCK STEPHEN FOfficerVice President; VP Biopharmaceutical Developmt; VP, Global Technical Ops92006–2013
VAN NEST GARY AOfficerVice President; VP, Preclinical Research22006–2007
DINA DINODirector; Director,OfficerCEO and Director; President and CEO; President, CEO and Director162006–2014
ORONSKY ARNOLD LDirector222006–2020
CARSON DENNISDirector362006–2019
DEERFIELD CAPITAL LPTenPercentOwner; TenPercentOwnerOther162006–2008
DEERFIELD INTERNATIONAL LTDTenPercentOwnerOther92006
DEERFIELD MANAGEMENT CO /NYTenPercentOwner; TenPercentOwnerOther162006–2008
DEERFIELD PARTNERS, LPTenPercentOwnerOther92006
Deerfield Special Situations Fund International LTDTenPercentOwner; TenPercentOwnerOther162006–2008
Deerfield Special Situations Fund, L.P.TenPercentOwner; TenPercentOwnerOther162006–2008
Buc Nancy LDirector72006–2010
GILBERT DENISEDirector112006–2014
JANNEY DANIELDirector; Other22006
LESCHLY JANDirector12006
Plotkin Stanley ADirector152006–2017
Phillips Peggy VDirector262006–2024
OSTRACH MICHAEL SOfficerChief Business Officer; Senior Vice President; Vice President; VP, CBO, and General Counsel362006–2021
LAWRENCE DAVID MDirector62006–2010
DEERFIELD PRIVATE DESIGAN FUND L PTenPercentOwner62007–2008
Deerfield Private Design International, L.P.TenPercentOwner52007–2008
JANOWICZ ZBIGNIEWDirector; OfficerCEO Dynavax Europe62008–2012
SANDERS MARTIN EOfficerEVP and CDO; EVP, Chief Development Officer32008
BIOTECHNOLOGY VALUE FUND II LPOther; TenPercentOwnerOther72008–2009
BIOTECHNOLOGY VALUE FUND L POther; TenPercentOwnerOther72008–2009
BVF INC/ILTenPercentOwner; TenPercentOwnerOther72008–2009
BVF INVESTMENTS LLCOther; TenPercentOwnerOther72008–2009
BVF PARTNERS L P/ILTenPercentOwner; TenPercentOwnerOther72008–2009
Lew JenniferOfficerPrincipal Accounting Officer; VP, Finance & PAO72009–2013
LAMPERT MARK NTenPercentOwner42009
CANO FRANCISDirector272009–2026
KESSEL MARKDirector; Director,TenPercentOwner82010–2012
SYMPHONY CAPITAL GP, L.P.Director,TenPercentOwnerOther22010
Symphony Capital Partners LPDirector,TenPercentOwnerOther22010
SYMPHONY GP, LLCDirector,TenPercentOwnerOther22010
SYMPHONY STRATEGIC PARTNERS LLCDirector,TenPercentOwnerOther22010
TARANTO HARRI VDirector,TenPercentOwnerOther22010
MARTIN J TYLERDirector,Officer; OfficerPresident & CMO; President, CMO & Director; VP Clinical Development & CMO82010–2012
KISNER DANIEL LDirector222010–2026
LARSON CHRISTINE ROfficerVP and Chief Financial Officer22012
Novack David FOfficerCo-President and Senior VP; President & COO; Senior Vice President642013–2026
Gray EddieDirector,OfficerCEO and Director202013–2019
RICCIARDI NATALE SDirector122013–2022
Janssen RobertOfficerChief Medical Officer and VP; Senior Vice President; SVP and CMO; Vice President562013–2025
Johnson David LouisOfficerVice President; Vice President & CAO252014–2020
Brege LauraDirector82015–2019
Spencer RyanDirector,Officer; OfficerCEO and Director; Co-President and Senior VP222019–2026
Hack Andrew A. F.Director162019–2023
Burgess JustinOfficerChief Accounting Officer; Principal Accounting Officer; VP Finance & CAO202020–2025
EASTLAND JULIA MARIEDirector62020–2024
MacGregor BrentDirector82020–2026
Paradiso Peter R.Director72020–2025
MacDonald KellyOfficerSVP and CFO122021–2026
Myers Scott DunsethDirector82021–2026
Sun Elaine DDirector72021–2026
Slebir John LOfficerSVP General Counsel62024–2026
Deep Track Biotechnology Master Fund, Ltd.TenPercentOwner32024–2026
Deep Track Capital, LPTenPercentOwner32024–2026
KROIN DAVIDTenPercentOwner32024–2026
Emini EmilioDirector42025–2026
SILVERNAIL LAUREN PDirector42025–2026
Metzinger Joseph AnthonyOfficerVP, Chief Accounting Officer42025–2026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationDYNAVAX TECHNOLOGIES CORPORATIONCAState business registriesEIN (EXACT, as the state registration reports it)
Business registrationDYNAVAX TECHNOLOGIES CORPORATIONCAState business registriesname and state
Business registrationDYNAVAX TECHNOLOGIES CORPORATIONCAState business registriesname and state
Business registrationDYNAVAX TECHNOLOGIES CORPORATIONCAState business registriesname and state
Business registrationDYNAVAX TECHNOLOGIES CORPORATIONCAState business registriesname and state
Business registrationDYNAVAX TECHNOLOGIES CORPORATIONCAState business registriesname and state
Business registrationDYNAVAX TECHNOLOGIES CORPORATIONCAState business registriesname and state
Federal award recipientDYNAVAX TECHNOLOGIES CORPORATIONCAFederal spending (USAspending)name and state
Lobbying clientDYNAVAX TECHNOLOGIESCAFederal lobbying (LDA)name and state
Lobbying clientDYNAVAX TECHNOLOGIESCAFederal lobbying (LDA)name and state
Lobbying clientDYNAVAX TECHNOLOGIES CORP.CAFederal lobbying (LDA)name and state
Lobbying registrantDYNAVAX TECHNOLOGIES CORP.CAFederal lobbying (LDA)name and state
Paying companyDynavax Technologies CorporationCAOpen Payments (drug and device company payments)name and state
Patent assigneeDYNAVAX TECHNOLOGIES CORPORATIONCAPatents (USPTO)name and state
SEC filerDYNAVAX TECHNOLOGIES CORPSEC filers (EDGAR)CIK (EXACT)
Trademark ownerDynavax Technologies CorporationCATrademarks (USPTO)name and state
Form 5500 plan sponsorDYNAVAX TECHNOLOGIESEIN (EXACT)
Person pageJames E FlynnPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health